Henrik Kummel

UZ.IP est une solution de gestion automatisée de preuves dusage en matière de marques.

We are a preclinical-stage biotech company focused on developing revolutionary therapies to address Inflammatory Bowel Diseases. Harnessing the unique capabilities of our Genetic Medicines Oral Delivery platform we aim to overcome major limitations of current treatments and unlock the groundbreaking potential of Genetic Medicines in IBDs, driving transformative change in a field with critical medical needs.

COSMYX is a French company specialized in 3D printing using Fused Filament Fabrication (FFF) technology. 🚀 We design and manufacture professional-grade NOVA and SUPER NOVA 3D printers, developed to meet the demands of industrial production. Our automated 3D microfactories, MIRA and NEXUS, enable continuous 24/7 manufacturing. We also offer on-demand 3D printing services, training for the use of our products, and a responsive customer support service based in Île-de-France. The company is committed to the "Industry of the Future" and provides innovative solutions to integrate the circular economy into industrial manufacturing, relocate production, and reduce environmental impact. ♻️

Skydrone Robotics company designs and manufactures solutions of drones, payloads and high-tech control stations, located between mass civilian products and large state systems; They are intended for the professional markets of observation, science, protection, Défense, security or transport and health.

EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohns fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field. The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.

AUSTRAL Dx is a French start-up developing a new imaging technology based upon airborne ultrasounds which will map vibrations originating from the lungs (directly or via vocal fremitus) or the heartbeat and appearing on the surface of the skin with a precision of 1 micron. This new device will accelerate and improve the diagnosis and the follow-up of lung and cardiac diseases.

UZ.IP est une solution de gestion automatisée de preuves dusage en matière de marques.

We are a preclinical-stage biotech company focused on developing revolutionary therapies to address Inflammatory Bowel Diseases. Harnessing the unique capabilities of our Genetic Medicines Oral Delivery platform we aim to overcome major limitations of current treatments and unlock the groundbreaking potential of Genetic Medicines in IBDs, driving transformative change in a field with critical medical needs.

COSMYX is a French company specialized in 3D printing using Fused Filament Fabrication (FFF) technology. 🚀 We design and manufacture professional-grade NOVA and SUPER NOVA 3D printers, developed to meet the demands of industrial production. Our automated 3D microfactories, MIRA and NEXUS, enable continuous 24/7 manufacturing. We also offer on-demand 3D printing services, training for the use of our products, and a responsive customer support service based in Île-de-France. The company is committed to the "Industry of the Future" and provides innovative solutions to integrate the circular economy into industrial manufacturing, relocate production, and reduce environmental impact. ♻️

Skydrone Robotics company designs and manufactures solutions of drones, payloads and high-tech control stations, located between mass civilian products and large state systems; They are intended for the professional markets of observation, science, protection, Défense, security or transport and health.

EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohns fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this new field. The company has successfully developed a multi-patented platform which enables exosome sourcing, generation, loading, and formulation to create proprietary programs and establish early-stage partnerships in the field of regenerative therapy and oncology.